Johannes Czernin

Dr. Johannes Czernin is a Professor and Vice Chair of the Department of Molecular and Medical Pharmacology at the David Geffen School of Medicine at UCLA. He also serves as Chief of the Ahmanson Translational Theranostics Division, and is involved in clinical and preclinical research programs. Dr. Czernin received his MD from the University of Vienna in 1983 and holds board certifications in Internal Medicine and Nuclear Medicine. His research focuses on prostate-specific membrane antigen (PSMA)-targeted theranostics for prostate cancer. Dr. Czernin will be speaking on “How Many Patients Can Benefit from PSMA Targeted Theranostics,” sharing insights into the potential reach of these advanced therapies